- Markets
- Healthcare
- KPL
KPL
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
India's Kwality Pharma gains on Saudi FDA nod for drugs
** Kwality Pharmaceuticals KWAL.BO rises 5% to 900.7 rupees
** Co gets Saudi Food and Drug Authority's approval for its general injectables and beta lactam, including penicillin and dry powder injectables
** Says certification will open new markets, including Saudi Arabia, UAE, Jordan, Bahrain and Kuwait
** Stock had surged more than two-fold in 2024
(Reporting by Ashna Teresa Britto in Bengaluru)
(([email protected] ; ( +91 8078332441))
** Kwality Pharmaceuticals KWAL.BO rises 5% to 900.7 rupees
** Co gets Saudi Food and Drug Authority's approval for its general injectables and beta lactam, including penicillin and dry powder injectables
** Says certification will open new markets, including Saudi Arabia, UAE, Jordan, Bahrain and Kuwait
** Stock had surged more than two-fold in 2024
(Reporting by Ashna Teresa Britto in Bengaluru)
(([email protected] ; ( +91 8078332441))
Kwality Pharmaceuticals Gets RCGM Approval To Advance For Pre-Clinical Studies Of Erythropoietin
Jan 2 (Reuters) - Kwality Pharmaceuticals Ltd KWAL.BO:
GETS RCGM APPROVAL TO ADVANCE FOR PRE-CLINICAL STUDIES OF ERYTHROPOIETIN
Source text: ID:nBSE24g3w1
Further company coverage: KWAL.BO
(([email protected];;))
Jan 2 (Reuters) - Kwality Pharmaceuticals Ltd KWAL.BO:
GETS RCGM APPROVAL TO ADVANCE FOR PRE-CLINICAL STUDIES OF ERYTHROPOIETIN
Source text: ID:nBSE24g3w1
Further company coverage: KWAL.BO
(([email protected];;))
Kwality Pharmaceuticals Receives Approval For Tamoxifen 20Mg Tablet In South Africa
Dec 24 (Reuters) - Kwality Pharmaceuticals Ltd KWAL.BO:
KWALITY PHARMACEUTICALS LTD - RECEIVES APPROVAL FOR TAMOXIFEN 20MG TABLET IN SOUTH AFRICA
Source text: ID:nBSE5X59j6
Further company coverage: KWAL.BO
(([email protected];))
Dec 24 (Reuters) - Kwality Pharmaceuticals Ltd KWAL.BO:
KWALITY PHARMACEUTICALS LTD - RECEIVES APPROVAL FOR TAMOXIFEN 20MG TABLET IN SOUTH AFRICA
Source text: ID:nBSE5X59j6
Further company coverage: KWAL.BO
(([email protected];))
Kwality Pharmaceuticals Gets Biological Product Permission For Pegylated-Asparaginase
Nov 26 (Reuters) - Kwality Pharmaceuticals Ltd KWAL.BO:
KWALITY PHARMACEUTICALS - GOT BIOLOGICAL PRODUCT PERMISSION FOR PEGYLATED-ASPARAGINASE
KWALITY PHARMACEUTICALS - PERMISSION FOR MAKING, SALE OF PEGYLATED-ASPARAGINASE
Source text: ID:nBSEb6qpYS
Further company coverage: KWAL.BO
(([email protected];))
Nov 26 (Reuters) - Kwality Pharmaceuticals Ltd KWAL.BO:
KWALITY PHARMACEUTICALS - GOT BIOLOGICAL PRODUCT PERMISSION FOR PEGYLATED-ASPARAGINASE
KWALITY PHARMACEUTICALS - PERMISSION FOR MAKING, SALE OF PEGYLATED-ASPARAGINASE
Source text: ID:nBSEb6qpYS
Further company coverage: KWAL.BO
(([email protected];))
Kwality Pharmaceuticals Gets Approval From Digemid, Peru
July 17 (Reuters) - Kwality Pharmaceuticals Ltd KWAL.BO:
GETS APPROVAL FROM DIGEMID, PERU
GETS APPROVAL FOR ITS GENERIC, INJECTABLE & OSD (UNIT -1 IN AMRITSAR)
Source text for Eikon: ID:nBSE93xBmj
Further company coverage: KWAL.BO
(([email protected];;))
July 17 (Reuters) - Kwality Pharmaceuticals Ltd KWAL.BO:
GETS APPROVAL FROM DIGEMID, PERU
GETS APPROVAL FOR ITS GENERIC, INJECTABLE & OSD (UNIT -1 IN AMRITSAR)
Source text for Eikon: ID:nBSE93xBmj
Further company coverage: KWAL.BO
(([email protected];;))
Kwality Pharmaceuticals Says Received INVIMA Approval For Ampoule, Vial Product Lines
April 22 (Reuters) - Kwality Pharmaceuticals Ltd KWAL.BO:
KWALITY PHARMA RECEIVED INVIMA APPROVAL FOR ITS AMPOULE AND VIAL PRODUCT LINES
APPROVAL FROM COLOMBIA'S INVIMA WILL ACCELERATE GROWTH IN COLOMBIA
APPROVAL EXPECTED TO AID REVENUE GROWTH IN COMING QUARTERS
Source text for Eikon: ID:nBSE6FV4Fd
Further company coverage: KWAL.BO
(([email protected];))
April 22 (Reuters) - Kwality Pharmaceuticals Ltd KWAL.BO:
KWALITY PHARMA RECEIVED INVIMA APPROVAL FOR ITS AMPOULE AND VIAL PRODUCT LINES
APPROVAL FROM COLOMBIA'S INVIMA WILL ACCELERATE GROWTH IN COLOMBIA
APPROVAL EXPECTED TO AID REVENUE GROWTH IN COMING QUARTERS
Source text for Eikon: ID:nBSE6FV4Fd
Further company coverage: KWAL.BO
(([email protected];))
Kwality Pharmaceuticals Says Fire Occurred At D Block Of Our Plant Situated At Village Nagkalan, Amritsar, Punjab On Oct 5
Oct 6 (Reuters) - Kwality Pharmaceuticals Ltd KWAL.BO:
KWALITY PHARMACEUTICALS LTD - FIRE OCCURRED AT D BLOCK OF OUR PLANT SITUATED AT VILLAGE NAGKALAN, AMRITSAR, PUNJAB ON OCT 5
KWALITY PHARMACEUTICALS LTD - FIRE INCIDENCE TOOK PLACE OUTSIDE MANUFACTURING BLOCK
KWALITY PHARMACEUTICALS LTD - FIRE SPREAD TO AHU AND PACKING AREA
KWALITY PHARMACEUTICALS LTD - FIRE WAS CONTROLLED
KWALITY PHARMACEUTICALS LTD - PRODUCTION OPERATION OF SAID PLANT IS TEMPORALLY DISTURBED
KWALITY PHARMACEUTICALS LTD - 4 OF OUR EMPLOYEES HAVE LOST THEIR LIVES IN INCIDENT DUE TO SMOKE SPREAD OVER AREA
KWALITY PHARMACEUTICALS LTD - COMPANY IS IN PROCESS OF ASCERTAINING CAUSE OF FIRE AND ACTUAL LOSS
Source text for Eikon: ID:nBSE11Pydk
Further company coverage: KWAL.BO
(([email protected];;))
Oct 6 (Reuters) - Kwality Pharmaceuticals Ltd KWAL.BO:
KWALITY PHARMACEUTICALS LTD - FIRE OCCURRED AT D BLOCK OF OUR PLANT SITUATED AT VILLAGE NAGKALAN, AMRITSAR, PUNJAB ON OCT 5
KWALITY PHARMACEUTICALS LTD - FIRE INCIDENCE TOOK PLACE OUTSIDE MANUFACTURING BLOCK
KWALITY PHARMACEUTICALS LTD - FIRE SPREAD TO AHU AND PACKING AREA
KWALITY PHARMACEUTICALS LTD - FIRE WAS CONTROLLED
KWALITY PHARMACEUTICALS LTD - PRODUCTION OPERATION OF SAID PLANT IS TEMPORALLY DISTURBED
KWALITY PHARMACEUTICALS LTD - 4 OF OUR EMPLOYEES HAVE LOST THEIR LIVES IN INCIDENT DUE TO SMOKE SPREAD OVER AREA
KWALITY PHARMACEUTICALS LTD - COMPANY IS IN PROCESS OF ASCERTAINING CAUSE OF FIRE AND ACTUAL LOSS
Source text for Eikon: ID:nBSE11Pydk
Further company coverage: KWAL.BO
(([email protected];;))
Kwality Pharmaceuticals Completed EU GMP Inspection For Its Cephalosporin And Oncology Manufacturing Unit II At Himachal Pradesh
April 24 (Reuters) - Kwality Pharmaceuticals Ltd KWAL.BO:
COMPLETED EU GMP INSPECTION FOR ITS CEPHALOSPORIN AND ONCOLOGY MANUFACTURING UNIT II AT HIMACHAL PRADESH
QUALITY SYSTEM FOLLOWED AT HIMACHAL SITE COMPLIANT WITH EU GMP STANDARDS
Source text for Eikon: ID:nBSEcbgyyL
Further company coverage: KWAL.BO
(([email protected];))
April 24 (Reuters) - Kwality Pharmaceuticals Ltd KWAL.BO:
COMPLETED EU GMP INSPECTION FOR ITS CEPHALOSPORIN AND ONCOLOGY MANUFACTURING UNIT II AT HIMACHAL PRADESH
QUALITY SYSTEM FOLLOWED AT HIMACHAL SITE COMPLIANT WITH EU GMP STANDARDS
Source text for Eikon: ID:nBSEcbgyyL
Further company coverage: KWAL.BO
(([email protected];))
Events:
Bonus
Dividend
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Kwality Pharma do?
Kwality Pharmaceuticals Ltd. is a pharmaceutical formation company manufacturing and exporting finished pharmaceutical formulations in various dosage forms since 1983, following new GMP norms.
Who are the competitors of Kwality Pharma?
Kwality Pharma major competitors are Wanbury, Anuh Pharma, Shivalik Rasayan, Sakar Healthcare, Bharat Parenterals, Prevest Denpro, Lincoln Pharma. Market Cap of Kwality Pharma is ₹849 Crs. While the median market cap of its peers are ₹868 Crs.
Is Kwality Pharma financially stable compared to its competitors?
Kwality Pharma seems to be less financially stable compared to its competitors. Altman Z score of Kwality Pharma is 5.19 and is ranked 4 out of its 8 competitors.
Does Kwality Pharma pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Kwality Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Kwality Pharma allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Accounts Receivable
How strong is Kwality Pharma balance sheet?
Balance sheet of Kwality Pharma is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Kwality Pharma improving?
Yes, profit is increasing. The profit of Kwality Pharma is ₹29.56 Crs for TTM, ₹23.8 Crs for Mar 2024 and ₹19.37 Crs for Mar 2023.
Is the debt of Kwality Pharma increasing or decreasing?
Yes, The debt of Kwality Pharma is increasing. Latest debt of Kwality Pharma is ₹94.75 Crs as of Sep-24. This is greater than Mar-24 when it was ₹86.39 Crs.
Is Kwality Pharma stock expensive?
Yes, Kwality Pharma is expensive. Latest PE of Kwality Pharma is 28.57, while 3 year average PE is 24.98. Also latest EV/EBITDA of Kwality Pharma is 12.56 while 3yr average is 7.38.
Has the share price of Kwality Pharma grown faster than its competition?
Kwality Pharma has given lower returns compared to its competitors. Kwality Pharma has grown at ~17.54% over the last 3yrs while peers have grown at a median rate of 20.17%
Is the promoter bullish about Kwality Pharma?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Kwality Pharma is 54.83% and last quarter promoter holding is 54.83%.
Are mutual funds buying/selling Kwality Pharma?
There is Insufficient data to gauge this.